Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy: The POSEIDON Randomized Trial

CONTEXT: Mesenchymal stem cells (MSCs) are under evaluation as a therapy for ischemic cardiomyopathy (ICM). Both autologous and allogeneic MSC therapies are possible; however, their safety and efficacy have not been compared. OBJECTIVE: To test whether allogeneic MSCs are as safe and effective as au...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA
Autori principali: Hare, Joshua M., Fishman, Joel E., Gerstenblith, Gary, DiFede Velazquez, Darcy L., Zambrano, Juan P., Suncion, Viky Y., Tracy, Melissa, Ghersin, Eduard, Johnston, Peter V., Brinker, Jeffrey A., Breton, Elayne, Davis-Sproul, Janice, Schulman, Ivonne H., Byrnes, John, Mendizabal, Adam M., Lowery, Maureen H., Rouy, Didier, Altman, Peter, Foo, Cheryl Wong Po, Ruiz, Phillip, Amador, Alexandra, Silva, Jose Da, McNiece, Ian K., Heldman, Alan W.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4762261/
https://ncbi.nlm.nih.gov/pubmed/23117550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2012.25321
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi